Patents by Inventor John Schrader

John Schrader has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN MONOCLONAL ANTIBODIES THAT NEUTRALIZE BIOACTIVITY OF GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR AND METHODS AND USES THEREOF
    Publication number: 20160024200
    Abstract: The present disclosure relates to an isolated human monoclonal antibody or antibody fragment that has a high potency for neutralizing the bioactivity of GM-CSF comprising the heavy chain CDR sequences of SEQ ID NOs: 1, 2 and 3 and the light chain CDR sequences of SEQ ID NOs: 7, 8 and 9, or functional variants thereof. The disclosure also relates to methods and uses of the antibody or antibody fragment for suppressing an immune response, heating inflammation, pain, cancer, and bone or cartilage loss.
    Type: Application
    Filed: March 6, 2014
    Publication date: January 28, 2016
    Inventor: John SCHRADER
  • Methods of isolating cells and generating monoclonal antibodies
    Patent number: 8945857
    Abstract: The invention provides methods for isolating cells, particularly antibody-secreting cells that have a high likelihood of secreting antibodies specific for a desired antigen for the purpose of making monoclonal antibodies.
    Type: Grant
    Filed: June 30, 2006
    Date of Patent: February 3, 2015
    Inventor: John Schrader
  • METHODS OF ISOLATING CELLS AND GENERATING MONOCLONAL ANTIBODIES
    Publication number: 20100255496
    Abstract: The invention provides methods for isolating cells, particularly antibody-secreting cells that have a high likelihood of secreting antibodies specific for a desired antigen for the purpose of making monoclonal antibodies.
    Type: Application
    Filed: June 30, 2006
    Publication date: October 7, 2010
    Inventor: John Schrader